Racura Oncology

(ASX) RAC

Current PriceA$2.40

Market CapA$468.08M

Since IPO (2016)+791%

5 Year-38%

1 Year+109%

1 Month-8%

Racura Oncology Financials at a Glance

Market Cap

A$468.08M

Revenue (TTM)

A$6.88M

Net Income (TTM)

-A$17.04M

EPS (TTM)

-A$0.05

P/E Ratio

-44.69

Dividend

A$0.00

Beta (Volatility)

-0.11 (Low)

Dividend

A$0.00

Beta (Volatility)

-0.11 (Low)

Price

A$2.40

Volume

86,148

Open

A$2.41

Price

A$2.40

Volume

86,148

Open

A$2.41

Previous Close

A$2.40

Daily Range

A$2.38 - A$2.46

52-Week Range

A$1.12 - A$4.90

Estimated Earnings Date

Sep 1, 2026

Dividend

A$0.00

Beta (Volatility)

-0.11 (Low)

Price

A$2.40

Volume

86,148

Open

A$2.41

Previous Close

A$2.40

Daily Range

A$2.38 - A$2.46

52-Week Range

A$1.12 - A$4.90

Estimated Earnings Date

Sep 1, 2026

RAC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Racura Oncology

Industry

Biotechnology

Sector

Health Care

CEO

Daniel Tillett, PhD

Website

www.raceoncology.com

Headquarters

Sydney, NSW 2000, AU

RAC Financials

Key Financial Metrics (TTM)

Gross Margin

50%

Operating Margin

-13%

Net Income Margin

-12%

Return on Equity

-42%

Return on Capital

-43%

Return on Assets

-38%

Earnings Yield

-2.24%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$468.08M

Shares Outstanding

195.03M

Volume

86.15K

Avg. Volume

208.88K

Financials (TTM)

Gross Profit

A$5.41M

Operating Income

-A$3.77M

EBITDA

-A$4.43M

Operating Cash Flow

-A$4.57M

Capital Expenditure

A$3.00

Free Cash Flow

-A$4.57M

Cash & ST Invst.

A$13.67M

Total Debt

A$0.00

Racura Oncology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

A$0.00

-100.0%

Gross Profit

-A$140.60K

+0.0%

Gross Margin

0.00%

N/A

Market Cap

A$468.08M

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

-A$4.10M

+27.6%

EBITDA

-A$5.52M

+42.1%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

A$20.94M

+52.7%

Total Debt

A$0.00

N/A

Accounts Receivable

A$32.30K

-99.2%

Inventory

A$0.00

N/A

Long Term Debt

A$0.00

N/A

Short Term Debt

A$0.00

N/A

Return on Assets

-37.91%

N/A

Return on Invested Capital

-43.24%

N/A

Free Cash Flow

-A$2.19M

+73.2%

Operating Cash Flow

-A$2.19M

+73.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CGS.AXCogstate Limited

CGS.AXCogstate LimitedA$2.74-0.36%

CUV.AXClinuvel Pharmaceuticals Limited

CUV.AXClinuvel Pharmaceuticals LimitedA$8.96+1.24%

OCA.AXOceania Healthcare Limited

OCA.AXOceania Healthcare LimitedA$0.58+0.87%

ACL.AXAustralian Clinical Labs Limited

ACL.AXAustralian Clinical Labs LimitedA$2.16+0.00%

HLS.AXHealius Limited

HLS.AXHealius LimitedA$0.36+5.88%

PGC.AXParagon Care Limited

PGC.AXParagon Care LimitedA$0.15-3.23%

PYC.AXPYC Therapeutics Limited

PYC.AXPYC Therapeutics LimitedA$1.22+3.39%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$160.95+0.19%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

NOKNokia

NOKNokia$14.80+0.05%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SMCISuper Micro Computer

SMCISuper Micro Computer$30.46-0.05%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

Questions About RAC

What is the current price of Racura Oncology?

Racura Oncology is trading at A$2.40 per share.

What is the 52-week range for Racura Oncology?

Over the past 52 weeks, Racura Oncology has traded between A$1.12 and A$4.90.

How much debt does Racura Oncology have?

As of the most recent reporting period, Racura Oncology reported total debt of A$0.00.

How much cash does Racura Oncology have on hand?

Racura Oncology reported A$13.67M in cash and cash equivalents in its most recent financial results.

What is Racura Oncology’s dividend yield?

Racura Oncology does not currently have a dividend yield.

Racura Oncology

Racura Oncology Financials at a Glance

RAC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Racura Oncology

RAC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Racura Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About RAC

What is the current price of Racura Oncology?

What is the 52-week range for Racura Oncology?

How much debt does Racura Oncology have?

How much cash does Racura Oncology have on hand?

What is Racura Oncology’s dividend yield?

Premium Investing Services